Skip to main content

TableĀ 5 Value based price for each country

From: Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer

Country Value based price (1 GDP per capita) Value based price (3 GDP per capita)
Congo 466 1392
Ethiopia 727 2012
Guinea 591 1659
Kenya 1395 4147
Namibia 5068 14,451
Nigeria 2832 7620
Rwanda 743 2179
Uganda 731 2083
Zambia 1332 3912
Zimbabwe 1139 3109
South Africa 5936 17,728